The company has three clinical CAR-T programmes backed by its precision-targeting cellular system Imod platform technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback